$4.80
0.091.91%
Last update: Nov 10, 4:00 PM
Evolent Health Inc
EVHNYSE
Evolent Health fell 6.5% from $5.04 to $4.71, behind the S&P 500's +9.8%. Its worst day was Jul 23 (−16.7%), and its low came Mar 30 at $2.17.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.08 beat the $0.02 estimate on $468.7M revenue (est. $468.8M); FY revenue guidance of $2.4B–$2.6B against the $2.4B consensus.
+22.7%, the year's best day · S&P 500 +0.8%
Story events cover the past 12 months · Times ET
Evolent Health closed at its lowest level of the year, 56.9% below where the year started.
−1.8% · S&P 500 −0.3%
Evolent Health shares rose 14.7%, while the S&P 500 rose 0.8%.
+14.7% · S&P 500 +0.8%
EPS of $-0.02 beat the $-0.07 estimate on $496.2M revenue (est. $533.6M); FY revenue guidance of $2.4B–$2.6B against the $2.5B consensus.
+11.5% · S&P 500 −0.3%
Evolent Health shares rose 15.9%, while the S&P 500 rose 0.4%.
+15.9% · S&P 500 +0.4%
Evolent Health closed at its highest level of the year, 22.8% above where the year started.
+4.6% · S&P 500 +0.4%
Evolent Health shares fell 16.7%, while the S&P 500 fell 1.2%.
−16.7%, the year's worst day · S&P 500 −1.2%
EPS of $0.02 beat the $-0.03 estimate on $652.5M revenue (est. $601.9M); FY revenue guidance of $2.6B–$2.7B against the $2.5B consensus.
+16.6% · S&P 500 −0.2%
EPS of $0.06 beat the $0.04 estimate on $725.4M revenue (est. $728.5M); FY revenue guidance of $2.6B–$2.7B against the $2.6B consensus.
−5.4% · S&P 500 −4.4%
Where it ended: a close of $4.71 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.15, revenue est. $763.2M).
Nothing in the past 12 months.
All EVH dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EVH and SPY from Benzinga historical bars. Not investment advice.
